Blood Grouping Reagents Market Size, Share, and Analysis, By Product (Consumables, Instruments), By Test Type (Blood Group and Phenotype, Antibody Screening, Cross-Matching Tests, Antibody Identification, Coombs Tests, Antigen Typing), By Technique (PCR-Based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology, Others), By End User (Hospitals, Blood Banks, Clinical Laboratories) and Regional Forecasts, 2022-2032
Blood Grouping Reagents Market Size, Share, and Analysis, By Product (Consumables, Instruments), By Test Type (Blood Group and Phenotype, Antibody Screening, Cross-Matching Tests, Antibody Identification, Coombs Tests, Antigen Typing), By Technique (PCR-Based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology, Others), By End User (Hospitals, Blood Banks, Clinical Laboratories) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW
Blood Grouping Reagents Market size was USD 1.21 billion in 2021 and projected to grow from USD 1.4 billion in 2023 to USD 2.9 billion by 2032, exhibiting a CAGR of 8.4% during the forecast period.
Blood Grouping Reagents are used to ascertain human antigens of blood group like ABO, Kell, MNS, and Rhesus blood group antigens). The RhD and the ABO blood group systems are the key essential blood groups in blood transfusions. Blood classes are identified by either a protein or a molecule (carbohydrate) like the ABO antigens of blood group or several other antigens on the surface of the human red blood cell.
MARKET HIGHLIGHTS
Blood Grouping Reagents Market is expected to reach USD 2.9 billion, growing at a CAGR of 8.4% during the forecast period owing to the rising demand for blood group typing and blood transfusions and growing cases of emergencies like road accidents. Moreover, the mounting penetration of healthcare and associated facilities is anticipated to boost the growth of the Blood Grouping Reagents Market over the forecast period.
Blood Grouping Reagents Market Segments:
Growth Drivers
Growing Need for Blood Transfusions is Expected to Boost the Market Growth
Increasing Awareness about the Advantages of Blood Donation is Expected to Boost the Market Growth
Restraint
Concerns Regarding Inconsistent Findings May Restrain the Market Growth
Key Players
PRODUCT OVERVIEW
Blood Grouping Reagents Market size was USD 1.21 billion in 2021 and projected to grow from USD 1.4 billion in 2023 to USD 2.9 billion by 2032, exhibiting a CAGR of 8.4% during the forecast period.
Blood Grouping Reagents are used to ascertain human antigens of blood group like ABO, Kell, MNS, and Rhesus blood group antigens). The RhD and the ABO blood group systems are the key essential blood groups in blood transfusions. Blood classes are identified by either a protein or a molecule (carbohydrate) like the ABO antigens of blood group or several other antigens on the surface of the human red blood cell.
MARKET HIGHLIGHTS
Blood Grouping Reagents Market is expected to reach USD 2.9 billion, growing at a CAGR of 8.4% during the forecast period owing to the rising demand for blood group typing and blood transfusions and growing cases of emergencies like road accidents. Moreover, the mounting penetration of healthcare and associated facilities is anticipated to boost the growth of the Blood Grouping Reagents Market over the forecast period.
Blood Grouping Reagents Market Segments:
- Product
- Consumables
- Instruments
- Test Type
- Blood Group and Phenotype
- Antibody Screening
- Cross-Matching Tests
- Antibody Identification
- Coombs Tests
- Antigen Typing
- Technique
- PCR-Based and Microarray Technique
- Assay-Based Techniques
- Massively Parallel Sequencing Techniques
- Serology
- Others
Growth Drivers
Growing Need for Blood Transfusions is Expected to Boost the Market Growth
Increasing Awareness about the Advantages of Blood Donation is Expected to Boost the Market Growth
Restraint
Concerns Regarding Inconsistent Findings May Restrain the Market Growth
Key Players
- Merck KGaA
- Cardinal Health
- Beckman Coulter Inc
- Bio-Rad Laboratories Inc
- Quotient Ltd.
- Tulip Diagnostics
- Diagast SAS
- Atlas Medical
- Fortress Diagnostics
- Alpha Laboratories
- BAG Diagnostics GmbH
- Haemokinesis Pty Ltd
- Aikang
- Rapid Labs Ltd
- Anamol Laboratories Pvt. Ltd.
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1.Regional Market Share
1.2. Business Trends
1.3. Blood Grouping Reagents Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Blood Grouping Reagents Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. BLOOD GROUPING REAGENTS MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. MARKET ANALYSIS
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2.Economic
8.2.3.Social
8.2.4.Technological
9. BLOOD GROUPING REAGENTS MARKET
9.1. Overview
9.2.Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
10.1.Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Product
10.3.1.1.Consumables
10.3.1.1.1.By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Instruments
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2.Market Share (%) 2022-2032F
10.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.By Test Type
10.3.2.1. Blood Group and Phenotype
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2.Market Share (%) 2022-2032F
10.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.2.Antibody Screening
10.3.2.2.1.By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3.Cross-Matching Tests
10.3.2.3.1.By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.4.Antibody Identification
10.3.2.4.1. By Value (USD Million) 2022-2032F
10.3.2.4.2.Market Share (%) 2022-2032F
10.3.2.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.5.Coombs Tests
10.3.2.5.1.By Value (USD Million) 2022-2032F
10.3.2.5.2.Market Share (%) 2022-2032F
10.3.2.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.6.Antigen Typing
10.3.2.6.1.By Value (USD Million) 2022-2032F
10.3.2.6.2. Market Share (%) 2022-2032F
10.3.2.6.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.By Technique
10.3.3.1. PCR-Based and Microarray Technique
10.3.3.1.1. By Value (USD Million) 2022-2032F
10.3.3.1.2.Market Share (%) 2022-2032F
10.3.3.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.2.Assay-Based Techniques
10.3.3.2.1.By Value (USD Million) 2022-2032F
10.3.3.2.2. Market Share (%) 2022-2032F
10.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.3.Massively Parallel Sequencing Techniques
10.3.3.3.1.By Value (USD Million) 2022-2032F
10.3.3.3.2.Market Share (%) 2022-2032F
10.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.4.Serology
10.3.3.4.1. By Value (USD Million) 2022-2032F
10.3.3.4.2.Market Share (%) 2022-2032F
10.3.3.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.5.Others
10.3.3.5.1. By Value (USD Million) 2022-2032F
10.3.3.5.2.Market Share (%) 2022-2032F
10.3.3.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.4.By End User
10.3.4.1. Serology
10.3.4.1.1.By Value (USD Million) 2022-2032F
10.3.4.1.2. Market Share (%) 2022-2032F
10.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.4.2.Blood Banks
10.3.4.2.1. By Value (USD Million) 2022-2032F
10.3.4.2.2.Market Share (%) 2022-2032F
10.3.4.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.4.3.Clinical Laboratories
10.3.4.3.1. By Value (USD Million) 2022-2032F
10.3.4.3.2.Market Share (%) 2022-2032F
10.3.4.3.3.Y-o-Y Growth (%) 2022-2032F
11.NORTH AMERICA BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test Type
11.3.2. By Product
11.3.3. By Technique
11.3.4. By End User
11.4.Country
11.4.1. United States
11.4.2.Canada
12. EUROPE BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test Type
12.3.2.By Product
12.3.3.By Technique
12.3.4.By End User
12.4. Country
12.4.1.Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. ASIA BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test Type
13.3.2.By Product
13.3.3.By Technique
13.3.4.By End User
13.4. Country
13.4.1.India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. MIDDLE EAST AND AFRICA BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test Type
14.3.2.By Product
14.3.3.By Technique
14.3.4. By End User
14.4. Country
14.4.1.Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. LATIN AMERICA BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test Type
15.3.2.By Product
15.3.3.By Technique
15.3.4.By End User
15.4. Country
15.4.1.Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. COMPETITIVE LANDSCAPE
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. COMPANY PROFILES
17.1.Merck KGaA
17.1.1.Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4.Company Assessment
17.1.4.1.Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. Cardinal Health
17.3. Beckman Coulter Inc
17.4. Bio-Rad Laboratories Inc
17.5. Quotient Ltd.
17.6. Tulip Diagnostics
17.7. Diagast SAS
17.8. Atlas Medical
17.9. Fortress Diagnostics
17.10. Alpha Laboratories
17.11.BAG Diagnostics GmbH
17.12. Haemokinesis Pty Ltd
17.13. Aikang
17.14. Rapid Labs Ltd
17.15. Anamol Laboratories Pvt. Ltd.
17.16. Other Prominent Players
18. APPENDIX
19. CONSULTANT RECOMMENDATION
1.1.Regional Market Share
1.2. Business Trends
1.3. Blood Grouping Reagents Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Blood Grouping Reagents Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. BLOOD GROUPING REAGENTS MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. MARKET ANALYSIS
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2.Economic
8.2.3.Social
8.2.4.Technological
9. BLOOD GROUPING REAGENTS MARKET
9.1. Overview
9.2.Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
10.1.Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Product
10.3.1.1.Consumables
10.3.1.1.1.By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Instruments
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2.Market Share (%) 2022-2032F
10.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.By Test Type
10.3.2.1. Blood Group and Phenotype
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2.Market Share (%) 2022-2032F
10.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.2.Antibody Screening
10.3.2.2.1.By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3.Cross-Matching Tests
10.3.2.3.1.By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.4.Antibody Identification
10.3.2.4.1. By Value (USD Million) 2022-2032F
10.3.2.4.2.Market Share (%) 2022-2032F
10.3.2.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.5.Coombs Tests
10.3.2.5.1.By Value (USD Million) 2022-2032F
10.3.2.5.2.Market Share (%) 2022-2032F
10.3.2.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.6.Antigen Typing
10.3.2.6.1.By Value (USD Million) 2022-2032F
10.3.2.6.2. Market Share (%) 2022-2032F
10.3.2.6.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.By Technique
10.3.3.1. PCR-Based and Microarray Technique
10.3.3.1.1. By Value (USD Million) 2022-2032F
10.3.3.1.2.Market Share (%) 2022-2032F
10.3.3.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.2.Assay-Based Techniques
10.3.3.2.1.By Value (USD Million) 2022-2032F
10.3.3.2.2. Market Share (%) 2022-2032F
10.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.3.Massively Parallel Sequencing Techniques
10.3.3.3.1.By Value (USD Million) 2022-2032F
10.3.3.3.2.Market Share (%) 2022-2032F
10.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.4.Serology
10.3.3.4.1. By Value (USD Million) 2022-2032F
10.3.3.4.2.Market Share (%) 2022-2032F
10.3.3.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.3.5.Others
10.3.3.5.1. By Value (USD Million) 2022-2032F
10.3.3.5.2.Market Share (%) 2022-2032F
10.3.3.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.4.By End User
10.3.4.1. Serology
10.3.4.1.1.By Value (USD Million) 2022-2032F
10.3.4.1.2. Market Share (%) 2022-2032F
10.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.4.2.Blood Banks
10.3.4.2.1. By Value (USD Million) 2022-2032F
10.3.4.2.2.Market Share (%) 2022-2032F
10.3.4.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.4.3.Clinical Laboratories
10.3.4.3.1. By Value (USD Million) 2022-2032F
10.3.4.3.2.Market Share (%) 2022-2032F
10.3.4.3.3.Y-o-Y Growth (%) 2022-2032F
11.NORTH AMERICA BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test Type
11.3.2. By Product
11.3.3. By Technique
11.3.4. By End User
11.4.Country
11.4.1. United States
11.4.2.Canada
12. EUROPE BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test Type
12.3.2.By Product
12.3.3.By Technique
12.3.4.By End User
12.4. Country
12.4.1.Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. ASIA BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test Type
13.3.2.By Product
13.3.3.By Technique
13.3.4.By End User
13.4. Country
13.4.1.India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. MIDDLE EAST AND AFRICA BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test Type
14.3.2.By Product
14.3.3.By Technique
14.3.4. By End User
14.4. Country
14.4.1.Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. LATIN AMERICA BLOOD GROUPING REAGENTS MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test Type
15.3.2.By Product
15.3.3.By Technique
15.3.4.By End User
15.4. Country
15.4.1.Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. COMPETITIVE LANDSCAPE
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. COMPANY PROFILES
17.1.Merck KGaA
17.1.1.Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4.Company Assessment
17.1.4.1.Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. Cardinal Health
17.3. Beckman Coulter Inc
17.4. Bio-Rad Laboratories Inc
17.5. Quotient Ltd.
17.6. Tulip Diagnostics
17.7. Diagast SAS
17.8. Atlas Medical
17.9. Fortress Diagnostics
17.10. Alpha Laboratories
17.11.BAG Diagnostics GmbH
17.12. Haemokinesis Pty Ltd
17.13. Aikang
17.14. Rapid Labs Ltd
17.15. Anamol Laboratories Pvt. Ltd.
17.16. Other Prominent Players
18. APPENDIX
19. CONSULTANT RECOMMENDATION
